Search research articles
Contact Us
Filters
Showing results (101-110 of 825) with videos related to
Page
of 83
Sort By:
Oncology (Williston Park, N.Y.)
|
July 1, 1987
Current status of chemotherapy for urothelial tract tumors
C N Sternberg, H I Scher
Hematology/Oncology Clinics of North America
|
February 1, 1992
Chemotherapy for metastatic bladder cancer
P W Kantoff, H I Scher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer
H I Scher, W K Kelly
Seminars in Oncology
|
September 11, 1999
Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man--clinical trials at Memorial Sloan-Kettering Cancer Center
S F Slovin, H I Scher
Nature Reviews. Neurology
|
March 10, 2010
Migraine: migraine with aura increases the risk of stroke
Ann I Scher, Lenore J Launer
Cephalalgia : an International Journal of Headache
|
August 10, 2013
Epidemiology and classification of post-traumatic headache: what do we know and how do we move forward? Comment on Lucas et al., "Prevalence and characterization of headache following mild TBI"
Ann I Scher, Teshamae S Monteith
Cancer
|
August 5, 1998
Detectable tumor cells in the blood and bone marrow: smoke or fire?
S F Slovin, H I Scher
Urologic Oncology
|
March 31, 2015
A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy
Gabriel P Haas, Howard I Scher
Surgical Oncology Clinics of North America
|
October 6, 1997
Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience
W R Fair, H I Scher
The Cancer Journal From Scientific American
|
July 1, 1997
'Casodex': defining the role of antiandrogens
J A McCaffrey, H I Scher
Page
of 83
Search research articles
Search
Showing results (101-110 of 825) with videos related to
Sort By:
Page
of 83
Oncology (Williston Park, N.Y.)
|
July 1, 1987
Current status of chemotherapy for urothelial tract tumors
C N Sternberg, H I Scher
Hematology/Oncology Clinics of North America
|
February 1, 1992
Chemotherapy for metastatic bladder cancer
P W Kantoff, H I Scher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1993
Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer
H I Scher, W K Kelly
Seminars in Oncology
|
September 11, 1999
Peptide and carbohydrate vaccines in relapsed prostate cancer: immunogenicity of synthetic vaccines in man--clinical trials at Memorial Sloan-Kettering Cancer Center
S F Slovin, H I Scher
Nature Reviews. Neurology
|
March 10, 2010
Migraine: migraine with aura increases the risk of stroke
Ann I Scher, Lenore J Launer
Cephalalgia : an International Journal of Headache
|
August 10, 2013
Epidemiology and classification of post-traumatic headache: what do we know and how do we move forward? Comment on Lucas et al., "Prevalence and characterization of headache following mild TBI"
Ann I Scher, Teshamae S Monteith
Cancer
|
August 5, 1998
Detectable tumor cells in the blood and bone marrow: smoke or fire?
S F Slovin, H I Scher
Urologic Oncology
|
March 31, 2015
A window into new drug development for urologic oncology. Part II: Bench-to-bedside research improves survival in urologic cancer, and the discovery of better biomarkers can help predict patient response, toxicity, and resistance to therapy
Gabriel P Haas, Howard I Scher
Surgical Oncology Clinics of North America
|
October 6, 1997
Neoadjuvant hormonal therapy plus surgery for prostate cancer. The MSKCC experience
W R Fair, H I Scher
The Cancer Journal From Scientific American
|
July 1, 1997
'Casodex': defining the role of antiandrogens
J A McCaffrey, H I Scher
Page
of 83